# NSAIDS Following Elective Lumbar Spine Fusion

> **NCT07743606** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Rothman Institute Orthopaedics** · enrollment: 428 (estimated)

## Conditions studied

- NSAID (Non-Steroidal Anti-Inflammatory Drug)
- Lumbar Spine Fusion
- Ketorolac
- Postoperative Pain

## Interventions

- **DRUG:** Ketorolac
- **DRUG:** Naproxen
- **OTHER:** Standard Postoperative Pain Management

## Key facts

- **NCT ID:** NCT07743606
- **Lead sponsor:** Rothman Institute Orthopaedics
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-07-08
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 428 (ESTIMATED)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07743606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07743606, "NSAIDS Following Elective Lumbar Spine Fusion". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07743606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*